Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 8,404,332	$ 1,834,018
Other current assets	836,756	540,053
Total current assets	9,241,088	2,374,071
Property and equipment, net	5,062	6,217
Other assets:
Goodwill	7,647,266	272,315
In-process research and development	118,600	118,600
Deferred financing costs	0	1,901
Total assets	17,012,016	2,773,104
Current liabilities:
Accounts payable	539,440	383,411
Accrued expenses	1,711,300	438,028
Total liabilities	2,250,740	821,439
Series B Convertible Redeemable Preferred stock, $0.0001 par value; none and 970,238 shares authorized, issued and outstanding at September 30, 2017 and December 31, 2016, respectively	0	8,022,219
Series A Convertible Redeemable Preferred stock, $0.0001 par value; none and 638,416 shares authorized, issued and outstanding at September 30, 2017 and December 31, 2016, respectively	0	4,114,221
Convertible Redeemable Preferred stock	0	12,136,440
Stockholders' equity:
Preferred stock, no par value; authorized 10,000,000 shares; none issued and outstanding	0	0
Common stock, $0.01 par value; authorized 150,000,000 shares; 6,450,766 and 2,450,000 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	645	246
Additional paid in capital	36,098,222	1,172,200
Accumulated deficit	(21,337,591)	(11,357,221)
Total stockholders' equity (deficit)	14,761,276	(10,184,775)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 17,012,016	$ 2,773,104